# NovaSom

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novasom

- Industry: Medical Devices & Equipment
- Headquarters: Glen Burnie, US
- Website: www.novasom.com
- Total disclosed funding: $20M
- Latest round: Series D (Sep 15, 2009)
- Investors on record: 4

## About

NovaSom, Inc. is a technology-focused company dedicated to delivering innovative solutions that enhance efficiency and connectivity for users, catering to both enterprise and consumer markets.Founded in 1992, NovaSom, Inc. is based in Glen Burnie, US and specializes in developing advanced technological solutions. The company has successfully completed 8 deals, with its most recent funding round being a VENTURE DEBT of USD 3.7 mn in March 2018, bringing the total amount raised to USD 34.69 mn. The CEO is John Spitznagel.Novasom specializes in the development and provision of innovative technological solutions tailored for their clientele. Their core product offerings include advanced devices and software designed for various applications, focusing on enhancing user experience and efficiency in daily operations. These products aim to address specific end-use cases, such as improving operational workflows, increasing productivity, and providing seamless connectivity for both individual and enterprise users. The company serves a diverse customer base that encompasses both B2B and B2C segments, catering to industries including healthcare, education, and technology. Novasom's products are marketed and sold in multiple geographical regions, with a significant presence in North America, Europe, and select emerging markets, ensuring a broad reach for their innovative solutions.The revenue structure of Novasom is built around a combination of direct sales and strategic partnerships, enabling flexible transaction frameworks with various stakeholders. Business transactions typically occur through direct-to-consumer sales as well as B2B agreements with retailers and wholesalers, facilitating a wide distribution network for their flagship products. Novasom offers a range of pricing plans designed to accommodate different customer needs, depending on the specific products or services selected. Key offerings include proprietary devices and software solutions that are designed to integrate seamlessly into existing systems, providing value through enhanced functionality and user engagement. The company’s revenue generation is thus closely tied to the success and adoption of these innovative solutions in the marketplace.With the funding raised in March 2018, NovaSom plans to invest in the development of new products aimed at expanding their technological offerings. The company is targeting entry into emerging markets in Asia and Latin America by the end of 2022, enhancing their global footprint. The recent VENTURE DEBT funding will support these expansion efforts and product development initiatives.

## Funding rounds

- Series D, Sep 15, 2009, $20M — MedVenture Associates, Quaker Partners Management, Emergent Medical Ventures, TPG Biotech

## Investors

- MedVenture Associates (https://capitalatlas.ai/funds/medventure-associates) — Series D
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series D
- Emergent Medical Ventures (https://capitalatlas.ai/funds/emergent-medical-ventures) — Series D
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series D